Cargando…
Nintedanib prevented fibrosis progression and lung cancer growth in idiopathic pulmonary fibrosis
A 76‐year‐old man with a past history of acute exacerbation (AE) and idiopathic pulmonary fibrosis (IPF) was treated with nintedanib because of decline in his forced vital capacity over time. A new small nodular lesion was visible on a computed tomography scan of the chest before initiation of ninte...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138540/ https://www.ncbi.nlm.nih.gov/pubmed/30237884 http://dx.doi.org/10.1002/rcr2.363 |